Literature DB >> 8925161

[Adenocarcinoma of the uterine cervix--retrospective clinico-pathologic study].

P Freitag1, J Macků, K Nouzová.   

Abstract

A group of 70 female patients with adenocarcinoma of the uterine cervix treated between 1976 and 1995 at the 2nd Department of Obstetrics and Gynaecology, 1st Faculty of Medicine, Charles University and General Hospital, Prague, was evaluated retrospectively. They represented 8.6% of all patients with cervical cancer in this period. The mean age was 57.9 years and increased according to the clinical stage of disease. Some features of the patient history were similar to those of endometrial cancer. The most frequent symptom was abnormal bleeding (70%). The limited importance of praebioptic diagnostic methods was confirmed. Better treatment results were achieved by the surgical or combined treatment in comparison with radiotherapy alone. From histological types the worst results had a clear cell carcinoma. The recurrence rate was 13.4%. The overall 5-year survival was 43.1% (68% for the stage 1, 40% for the stage 2 and 22% for the stages 3 + 4). The average survival time was 96.1 months.

Entities:  

Mesh:

Year:  1996        PMID: 8925161

Source DB:  PubMed          Journal:  Ceska Gynekol        ISSN: 1210-7832


  2 in total

1.  Bone involvement by adenocarcinoma of the uterine cervix: a rare entity.

Authors:  Vincenzina Crisci; Pier Paolo Mainenti; Fabio Corvino; Rossella Lauria; Simone Maurea
Journal:  Pol J Radiol       Date:  2015-02-14

2.  Clear cell adenocarcinoma of the uterine cervix in a 24-year-old woman. Case report and review of the literature.

Authors:  Leszek Gottwald; Jerzy Korczyński; Ewa Góra; Renata Kusińska; Ewa Rogowska; Katarzyna Wójcik-Krowiranda; Andrzej Bieńkiewicz
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.